MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 72 filers reported holding MILLENDO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 9.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $212,000 | – | 40,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,396,615 | $16,145,000 | 4.14% |
| GREAT POINT PARTNERS LLC | 1,288,093 | $14,891,000,000 | 1.65% |
| NEA Management Company, LLC | 1,766,779 | $20,424,000 | 1.43% |
| Bpifrance SA | 1,078,670 | $12,469,000 | 1.34% |
| ADAMS STREET PARTNERS LLC | 409,146 | $4,730,000 | 0.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,825 | $2,056,000 | 0.76% |
| Prosight Management, LP | 73,868 | $854,000 | 0.43% |
| Samsara BioCapital, LLC | 45,101 | $521,000 | 0.34% |
| AWM Investment Company, Inc. | 77,629 | $897,000 | 0.17% |
| GMT CAPITAL CORP | 53,419 | $618,000 | 0.02% |